Holly LaDuca
0000-0002-3745-9072
Ambry Genetics Corp
5 papers found
Refreshing results…
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C
Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment
Classification of the canonical splice alteration MUTYH c.934-2A > G is likely benign based on RNA and clinical data
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
Genotype–phenotype associations among panel-based TP53+ subjects
Missing publications? Search for publications with a matching author name.